EA202091395A1 - DERIVATIVES OF 1,3,4,5-TETRAHYDRO-2H-PYRIDO [4,3-b] INDOL FOR TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES SUCH AS ALZHEIMER'S DISEASE - Google Patents
DERIVATIVES OF 1,3,4,5-TETRAHYDRO-2H-PYRIDO [4,3-b] INDOL FOR TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES SUCH AS ALZHEIMER'S DISEASEInfo
- Publication number
- EA202091395A1 EA202091395A1 EA202091395A EA202091395A EA202091395A1 EA 202091395 A1 EA202091395 A1 EA 202091395A1 EA 202091395 A EA202091395 A EA 202091395A EA 202091395 A EA202091395 A EA 202091395A EA 202091395 A1 EA202091395 A1 EA 202091395A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- alzheimer
- disease
- pyrido
- indol
- tetrahydro
- Prior art date
Links
Abstract
Настоящее изобретение относится к новым соединениям, которые можно применять для лечения, облегчения или профилактики группы расстройств и аномалий, связанных с агрегатами тау-белка (связанного с тубулином), включая, но не ограничиваясь этим, нейрофибриллярные клубки (NFT), например болезнь Альцгеймера (AD).The present invention relates to novel compounds that can be used to treat, alleviate or prevent a group of disorders and abnormalities associated with aggregates of tau protein (associated with tubulin), including, but not limited to, neurofibrillary tangles (NFT), such as Alzheimer's disease ( AD).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18175852 | 2018-06-04 | ||
PCT/EP2019/050180 WO2019134978A1 (en) | 2018-01-05 | 2019-01-04 | 1, 3, 4, 5-tetrahydro-2h-pyrido[4,3-b]indole derivatives for the treatment, alleviation or prevention of disorders associated with tau aggregates like alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202091395A1 true EA202091395A1 (en) | 2020-10-01 |
Family
ID=62530124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202091395A EA202091395A1 (en) | 2018-06-04 | 2019-01-04 | DERIVATIVES OF 1,3,4,5-TETRAHYDRO-2H-PYRIDO [4,3-b] INDOL FOR TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES SUCH AS ALZHEIMER'S DISEASE |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR117560A1 (en) |
EA (1) | EA202091395A1 (en) |
TW (1) | TWI812677B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008036021A1 (en) * | 2006-09-20 | 2008-03-27 | Astrazeneca Ab | Tetrahydro-lh-pyrido [3,4 -b] indole derivatives as cbl receptor ligands |
TWI498328B (en) * | 2008-01-25 | 2015-09-01 | Medivation Technologies Inc | New 2,3,4,5-tetrahydro-1h-pyrido(4,3-b)indole compounds and methods of use thereof |
CA2745085C (en) * | 2008-12-18 | 2018-03-06 | Merck Patent Gmbh | Tricyclic azaindoles |
DK2558446T5 (en) * | 2010-04-16 | 2019-12-09 | Ac Immune Sa | New compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
-
2019
- 2019-01-04 EA EA202091395A patent/EA202091395A1/en unknown
- 2019-03-04 TW TW108107135A patent/TWI812677B/en active
- 2019-03-08 AR ARP190100567A patent/AR117560A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW202017923A (en) | 2020-05-16 |
TWI812677B (en) | 2023-08-21 |
AR117560A1 (en) | 2021-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500573A1 (en) | 1,3,4,5-tetrahydro-2h-pyrido[4,3-b]indole derivatives for the treatment, alleviation or prevention of disorders associated with tau aggregates like alzheimer`s disease | |
WO2020176597A9 (en) | N-substituted indoles and other heterocycles for treating brain disorders | |
EA202092557A1 (en) | TETRAHYDROBENZOFURO [2,3-c] PYRIDINE AND BETA-CARBOLINE COMPOUNDS FOR TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU-PROTEIN UNITS | |
MX2021010193A (en) | Azepino-indoles and other heterocycles for treating brain disorders. | |
MA42560A (en) | COMPOSITIONS INCLUDING BACTERIAL STRAINS OF BLAUTIA FOR THE TREATMENT OF VISCERAL HYPERSENSITIVITY | |
EA201991375A1 (en) | BICYCLO [1.1.1] PENTANE KINASE INHIBITORS CONTAINING A DOMAIN WITH TWO LEUCINE "Zipper" (DLK) FOR THE TREATMENT OF THE DISEASE | |
EA201691447A1 (en) | 2-AMINO-3,5,5-TRIFTOR-3,4,5,6-TETRAGIDROPYRIDINES AS BACE1 INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
EA201990450A1 (en) | KINASE INHIBITORS CONTAINING A DOMAIN WITH TWO LEUCINE "Zipper" (DLK) FOR THE TREATMENT OF A DISEASE | |
MX2021013422A (en) | Kcnt1 inhibitors and methods of use. | |
MX2021013421A (en) | Kcnt1 inhibitors and methods of use. | |
EP4279127A3 (en) | Growth differentiation factor 15 as biomarker for metformin | |
MX2017011598A (en) | Methods for treating proteinopathies. | |
MX2019014300A (en) | Agent for preventing or treating tauopathy. | |
CO2019014090A2 (en) | Agents, uses and methods for treatment | |
WO2019075456A3 (en) | Methods and substances for prevention and treatment of neurodegenerative diseases | |
MX2022011518A (en) | Methods of treating proteinopathy- associated wandering. | |
EA202190576A1 (en) | POLYMORPHIC COMPOUNDS AND THEIR APPLICATION | |
MX2019014306A (en) | Amyloid-î² protein level decreasing agent. | |
MA38369A1 (en) | Peptides and compositions for the treatment of a lesion of the joint | |
MX2021002652A (en) | Use of casein kinase 1 inhibitors for treating vascular diseases. | |
WO2019165158A8 (en) | Il-6 inhibitors and methods of treatment | |
EA202090555A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING BETA AMYLOID ANTIBODIES | |
EA202091395A1 (en) | DERIVATIVES OF 1,3,4,5-TETRAHYDRO-2H-PYRIDO [4,3-b] INDOL FOR TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES SUCH AS ALZHEIMER'S DISEASE | |
MA55351A (en) | NOVEL COMPOUNDS FOR THE TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU PROTEIN AGGREGATES | |
MX2021007460A (en) | Peptides for treatment and prevention of diabetes and associated disorders. |